Go back

SFU associate professor Jiguo Cao renewed as Tier 2 Canada Research Chair

News

There are only 10 Canada Research Chairs in statistics

EIC
EIC
1 min.
0
1720
PHOTO: National Cancer Institute / Unsplash

by Jaymee Salisi, News Writer

Initially nominated in 2015 for Tier 1 of the program, Jiguo Cao was renewed as a Tier 2 Canada Research Chair in data science. With this title, Cao takes on the responsibility of promoting and leading research within his area.

Cao told The Peak in an interview that this position is meant to provide leadership to new researchers in their careers by conducting research in areas such as the prevention of Alzheimer’s disease and the advancement of artificial intelligence. 

Data science involves extracting information through statistics to gain insights on a subject. It is an interdisciplinary field, according to Cao, so he works with collaborators from various countries to gather and analyze data in his research areas. 

“I serve as the bridge between the data and the application problem we want to solve,” Cao said. He explained that researchers from different application areas provide him with data and he looks for the association between the circumstances and the complication. 

Cao currently studies how healthcare systems in different countries affect the COVID-19 death rate, as well as the survival time of breast cancer. “One central role in statistics is to try to answer the questions based on the data,” he said. Cao explained that this area of research involves the analysis of mammogram images provided by researchers of subjects with and without breast cancer. Comparing the image data helps him predict cancer survival.

Experienced as a statistics and actuarial science associate professor at SFU, Cao is also an associate editor of multiple publications including the Canadian Journal of Statistics and the Journal of Agricultural, Biological, and Environmental Statistics. 

He expressed that holding a position as a Canada Research Chair for data science is a prestigious title, as there are only 10 Chairs across Canada in the statistics department. 33 Chairs are currently appointed at SFU. 

The Canada Research Chair Program “invests approximately $259 million per year” to support  program members and make Canada a top country in research and development. Chairholders exist in a range of areas including engineering, health sciences, and humanities. Each Tier 2 Chair receives $100,000 towards their research annually for five years.

Was this article helpful?
0
0

Leave a Reply

Block title

New immunotherapy treatment provides hope for aggressive cancer

News Peak Web -
By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Read Next

Block title

New immunotherapy treatment provides hope for aggressive cancer

News Peak Web -
By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Block title

New immunotherapy treatment provides hope for aggressive cancer

News Peak Web -
By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Simon Fraser University’s independent student newspaper since 1965.

For advertising inquiries: [email protected]
For promotional inquiries: [email protected]

© The Peak Publications Society

Simon Fraser University’s independent student newspaper since 1965.

For advertising inquiries: [email protected]
For promotional inquiries: [email protected]

© The Peak Publications Society